Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial

The main objective of this pilot clinical trial was to evaluate outcome measures for the assessment of the nonsteroidal anti-inflammatory drug (NSAID) robenacoxib in cats with degenerative joint disease-associated pain (DJD-pain). Otherwise healthy cats (n = 109) with DJD-pain entered a parallel gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrian, Derek, King, Jonathan N., Parrish, Rudolph S., King, Stephen B., C. Budsberg, Steven, Gruen, Margaret E., Lascelles, B. Duncan X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032665/
https://www.ncbi.nlm.nih.gov/pubmed/33833276
http://dx.doi.org/10.1038/s41598-021-87023-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032665/
https://www.ncbi.nlm.nih.gov/pubmed/33833276
http://dx.doi.org/10.1038/s41598-021-87023-2

Ejemplares similares